NL-OMON38368已完成不适用
Determining the optimal dry powder adenosine provocation test to assess small airways disease - Impact
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •A docter*s diagnosis of asthma
- •Age: 18-65 years
- •PC20 methacholine-bromide <= 4.9mg/ml
- •Non-smoker
排除标准
- •Steroid use 4 weeks before entry into the baseline period
- •Recent exacerbation asthma (<2 months) or upper respiration tract infection (<2 weeks)
- •Severe airway obstruction at baseline, FEV1pred < 50%or < 1.2L
- •Diagnosis of COPD or any other pulmonary disease that could influence the study results as judged by the investigator
- •Pregnancy or lactating women
研究者
相似试验
已完成
不适用
Determining the Optimal Adenosine Provocation TestAsthmaNCT01610921University Medical Center Groningen11
已完成
不适用
Adenosine testing to determine the need for pacing therapy in unexplained syncopeCirculatory SystemBradycardia, unspecifiedSyncopeISRCTN62199741ewcastle upon Tyne NHS Foundation Trust (UK)180
已完成
不适用
To evaluate whether intravenous Adenosine would replace the need for inhaled nitric oxide (iNO) in the management of Persistent Pulmonary Hypertension of the Newborn (PPHN)eonatal Diseases: Persistant pulmonary hypertensionNeonatal DiseasesOther pulmonary heart diseasesISRCTN51768118Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)9
已完成
不适用
Rapid Measurement of Adenosine in Syncope PatientsSyncopeNCT05782712Istituto Auxologico Italiano235
已完成
1 期
Adenosine, lidocaone, and magnasium cocktail in massive transfusion patientsrepairfusion injury.IRCT20230707058707N1Shiraz University of Medical Sciences17